Leadership

Over 20 years of experience in the healthcare industry. Former surgical technologies executive at Johnson & Johnson Ethicon. Leads VVT Med's global strategy, commercialization, and corporate development.

Responsible for VVT Med's financial management, reporting, and capital markets activities. Oversees financial controls, investor relations communications, and TSXV compliance obligations.

Oversees day-to-day operations, manufacturing, supply chain, and global distribution execution. Drives operational efficiency across VVT Med's commercial markets.

Leads the engineering and product development team responsible for advancing VVT Med's ScleroSafe™ and V-Block™ platforms. Oversees design verification, technical file management, and next-generation innovation.

Responsible for maintaining VVT Med's FDA 510(k) clearance and CE Mark approvals, quality management systems, and global regulatory submissions across all commercial markets.

Leads global marketing strategy, brand development, clinical education, and physician engagement programs across VVT Med's international distribution network spanning the EU, US, Asia, and the Middle East.

Drives revenue growth and distributor relationships across VVT Med's commercial territories. Responsible for channel development, key account management, and market expansion initiatives.

Core member of VVT Med's research and development team. Contributes to the engineering design, testing, and technical development of the ScleroSafe™ and V-Block™ device platforms.

Leading vascular surgeon and nationally recognized authority in venous disease treatment. Director of the Center for Vein Disease at Englewood Health, New Jersey, and a prominent voice in minimally invasive vascular interventions.

System Chief for Venous Disease at Northwell Health and former President of the American Venous Forum. One of the foremost academic leaders in venous and lymphatic medicine in the United States.

Director of the Center for Comprehensive Venous Care at University Hospitals Harrington Heart & Vascular Institute. Specializes in advanced venous interventions and clinical outcomes research.

Chief of Vascular Surgery at Albany Medical Center and incoming President of the American Venous Forum. A nationally recognized vascular surgeon with expertise in venous and endovascular disease management.

Clinical Professor of Surgery at NYU Langone Health and Chancellor of Vein & Lymphatic University. A global pioneer in endovenous thermal and non-thermal ablation with extensive teaching and clinical research contributions.

Chief of Vascular and Endovascular Surgery at SANA Hospitals, Germany. Brings European clinical perspective and deep expertise in minimally invasive vascular procedures, supporting VVT Med's EU market expansion.